The accuracy of self-reported blood pressure in the Medication adherence Improvement Support App For Engagement - Blood Pressure (MedISAFE-BP) Trial: Implications for Pragmatic Trials.
Haff N, Lauffenburger JC, Morawski K, Ghazinouri R, Noor N, Kumar S, Juusola J, Choudhry NK.
Am Heart J
Association of a smartphone application with medication adherence and blood pressure control - The MedISAFE-BP randomized clinical trial.
Morawski K, Ghazinouri R, Krumme A, Lauffenburger JC, Lu Z, Durfee E, Oley L, Lee J, Mohta N, Haff N, Juusola JL, Choudhry NK.
JAMA Intern Med
Rationale and design of the Medication adherence Improvement Support App For Engagement - Blood Pressure (MedISAFE-BP) trial.
Morawski K, Ghazinouri R, Krumme A, McDonough J, Durfee E, Oley L, Mohta N, Juusola J, Choudhry NK.
Am Heart J
Hypertension-related deaths amount to 9.4 million deaths each year. Despite existing medications for treatment, medication non-adherence serves as a barrier to effective treatment. With the rapid adoption of smartphone technologies, previous studies have examined the impact on hypertension of a smartphone application, but the impact of a stand-alone smartphone application on blood pressure had not been tested in a rigorous manner with regards to hypertension control. The Medication Adherence Improvement Support App For Engagement—Blood Pressure (MediSAFE-BP) study randomized 411 patients with poorly-controlled hypertension to the Medisafe smartphone app or control and found that the app resulted in small but significant improvements in medication adherence but did not impact blood pressure control.
Principal Investigator: Niteesh Choudhry, MD, PhD